Chemical Name: 1-[(2,6-Dichlorophenyl)methyl]-3-hexadecyl-2-methylimidazol-1-ium iodide. Alternate Names: LXY-05-029
Aldolase inhibitor
Molekulargewicht:
593.46
Reinheit:
>98% by TLC NMR (Conforms)
Formulierung:
White to off-white solid
CAS Nummer:
[2904601-67-6]
Formel:
C27H43Cl2IN2
Anwendungsbeschreibung:
Aldometanib inhibits (IC50 = 50 µM) aldolase by blocking its binding with fructose-1,6-bisphosphate (FBP).1 It activates lysosomal AMPK and mimics a cellular state of glucose starvation. Aldometanib alleviated fatty liver and nonalcoholic steatohepatitis in mice and extended lifespan. It mitigated inflammation and oxidative stress damage in LPS-treated lung fibroblasts and also inhibited NLRP3-mediated pyroptosis.2 Aldometanib inhibited hepatocellular carcinoma in mice in an AMPK-dependent manner.3 It rebalanced the tumor microenvironment allowing cytotoxic CD8+ T cells to infiltrate tumor cells.
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten